We honoured to announce that we’ve been awarded Phase One funding from an initiative with the SBIR (Small Business Innovation Research), Enterprise Ireland and the Health Service Executive (HSE).
The joint goal was delivering improved patient care through intelligent use of technology while specifically targeted two areas:
1. Reducing the risk of women developing Type 2 diabetes following gestational diabetes.
2. Screening for diabetic foot disease in all patients with diabetes.
Our objective is to progress to Phase 2 with a positive contribution. We are looking forward to
working with HSE diabetes clinicians to test the feasibility of our ideas and innovations.